![]() 世界および米国のCefepime市場の洞察、2027年までの予測Global and United States Cefepime Market Insights, Forecast to 2027 セフェピムは、第4世代のセファロスポリンです。その抗菌スペクトルはさらに拡大されており、腸内細菌、緑膿菌などの非醗酵菌、ヘモフィルス、ブドウ球菌など、さまざまなグラム陽性菌および陰性菌に対して強い抗... もっと見る
![]()
※当ページの内容はウェブ更新時の情報です。
サマリーセフェピムは、第4世代のセファロスポリンです。その抗菌スペクトルはさらに拡大されており、腸内細菌、緑膿菌などの非醗酵菌、ヘモフィルス、ブドウ球菌など、さまざまなグラム陽性菌および陰性菌に対して強い抗菌力を有しています。感受性の高い細菌による各種感染症、主に黄色ブドウ球菌、大腸菌、緑膿菌などの副反応による呼吸器感染症に使用されます。市場分析と洞察。世界および米国のCefepime市場 当レポートでは、世界および米国のCefepime市場に焦点を当てています。 2020年のCefepimeの世界市場規模はXX百万米ドルで、2021-2027年の間にXX%のCAGRで、2027年末までにXX百万米ドルに達すると予想されています。米国では、Cefepimeの市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルまで、予測期間中にXX%のCAGRで成長すると予想されています。 世界のCefepimeの範囲と市場規模 Cefepime市場は、地域(国)別、プレイヤー別、タイプ別、アプリケーション別に分類されています。世界のCefepime市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年までの地域(国)別、タイプ別、アプリケーション別の収益と予測に焦点を当てています。 米国市場では、2016-2027年のCefepimeの市場規模を、プレイヤー別、タイプ別、アプリケーション別に調査しています。主要なプレイヤーには、米国で重要な役割を果たす世界的なプレイヤーや地域のプレイヤーが含まれます。 タイプ別セグメント 筋肉内注射 静脈内ドラッグデリバリー アプリケーション別 下部呼吸器系感染症 泌尿器系感染症 皮膚・軟部組織感染症 腹腔内感染症 婦人科領域の感染症 敗血症 好中球性発熱 地域別 北アメリカ U.S. カナダ ヨーロッパ ドイツ フランス イギリス イタリア ロシア アジアパシフィック 中国 日本 韓国 インド オーストラリア 台湾 インドネシア タイ マレーシア フィリピン ベトナム ラテンアメリカ メキシコ ブラジル アルゼンチン 中近東・アフリカ トルコ サウジアラビア UAE 会社別 バクスター Apotex ビー・ブラウン・メディカル ファイザー ペリゴ フレゼニウス・カビ サンドス(ノバルティス)社 ピラマル クリティカルケア Meitheal Pharmaceuticals BMS Qilu製薬 シノファーム 上海新豊製薬 河北華敏製薬 南京海健製薬 山東洛神製薬グループ 広州白雲山天心製薬 岳康製薬グループ 成都北投製薬 江蘇省Hengrui製薬 海南スター製薬 海南海鈴製薬(株) 深圳新里泰製薬 深圳麗澤医薬有限公司 蘇州東瑞製薬 目次1 Study Coverage1.1 Cefepime Product Introduction 1.2 Market by Type 1.2.1 Global Cefepime Market Size Growth Rate by Type 1.2.2 Intramuscular Injection 1.2.3 Intravenous Drug Delivery 1.3 Market by Application 1.3.1 Global Cefepime Market Size Growth Rate by Application 1.3.2 Lower Respiratory Tract Infection 1.3.3 Urinary Tract Infection 1.3.4 Skin And Soft Tissue Infections 1.3.5 Abdominal Cavity Infection 1.3.6 Gynecologic Infection 1.3.7 Sepsis 1.3.8 Neutrophilic Fever 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Cefepime Market Size, Estimates and Forecasts 2.1.1 Global Cefepime Revenue 2016-2027 2.1.2 Global Cefepime Sales 2016-2027 2.2 Global Cefepime, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Cefepime Historical Market Size by Region (2016-2021) 2.3.1 Global Cefepime Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Cefepime Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Cefepime Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Cefepime Sales Forecast by Region (2022-2027) 2.4.2 Global Cefepime Revenue Forecast by Region (2022-2027) 3 Global Cefepime Competitor Landscape by Players 3.1 Global Top Cefepime Manufacturers by Sales 3.1.1 Global Cefepime Sales by Manufacturer (2016-2021) 3.1.2 Global Cefepime Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Cefepime Manufacturers by Revenue 3.2.1 Key Cefepime Manufacturers Covered: Ranking by Revenue 3.2.2 Global Cefepime Revenue by Manufacturers (2016-2021) 3.2.3 Global Cefepime Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Cefepime Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Cefepime Revenue in 2020 3.2.6 Global Cefepime Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Cefepime Price by Manufacturers 3.4 Global Cefepime Manufacturing Base Distribution, Product Types 3.4.1 Cefepime Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Cefepime Product Type 3.4.3 Date of International Manufacturers Enter into Cefepime Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Cefepime Market Size by Type (2016-2021) 4.1.1 Global Cefepime Sales by Type (2016-2021) 4.1.2 Global Cefepime Revenue by Type (2016-2021) 4.1.3 Cefepime Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Cefepime Market Size Forecast by Type (2022-2027) 4.2.1 Global Cefepime Sales Forecast by Type (2022-2027) 4.2.2 Global Cefepime Revenue Forecast by Type (2022-2027) 4.2.3 Cefepime Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Cefepime Market Size by Application (2016-2021) 5.1.1 Global Cefepime Sales by Application (2016-2021) 5.1.2 Global Cefepime Revenue by Application (2016-2021) 5.1.3 Cefepime Price by Application (2016-2021) 5.2 Cefepime Market Size Forecast by Application (2022-2027) 5.2.1 Global Cefepime Sales Forecast by Application (2022-2027) 5.2.2 Global Cefepime Revenue Forecast by Application (2022-2027) 5.2.3 Global Cefepime Price Forecast by Application (2022-2027) 6 United States by Players, Type and Application 6.1 United States Cefepime Market Size YoY Growth 2016-2027 6.1.1 United States Cefepime Sales YoY Growth 2016-2027 6.1.2 United States Cefepime Revenue YoY Growth 2016-2027 6.1.3 United States Cefepime Market Share in Global Market 2016-2027 6.2 United States Cefepime Market Size by Players (International and Local Players) 6.2.1 United States Top Cefepime Players by Sales (2016-2021) 6.2.2 United States Top Cefepime Players by Revenue (2016-2021) 6.3 United States Cefepime Historic Market Review by Type (2016-2021) 6.3.1 United States Cefepime Sales Market Share by Type (2016-2021) 6.3.2 United States Cefepime Revenue Market Share by Type (2016-2021) 6.3.3 United States Cefepime Price by Type (2016-2021) 6.4 United States Cefepime Market Estimates and Forecasts by Type (2022-2027) 6.4.1 United States Cefepime Sales Forecast by Type (2022-2027) 6.4.2 United States Cefepime Revenue Forecast by Type (2022-2027) 6.4.3 United States Cefepime Price Forecast by Type (2022-2027) 6.5 United States Cefepime Historic Market Review by Application (2016-2021) 6.5.1 United States Cefepime Sales Market Share by Application (2016-2021) 6.5.2 United States Cefepime Revenue Market Share by Application (2016-2021) 6.5.3 United States Cefepime Price by Application (2016-2021) 6.6 United States Cefepime Market Estimates and Forecasts by Application (2022-2027) 6.6.1 United States Cefepime Sales Forecast by Application (2022-2027) 6.6.2 United States Cefepime Revenue Forecast by Application (2022-2027) 6.6.3 United States Cefepime Price Forecast by Application (2022-2027) 7 North America 7.1 North America Cefepime Market Size YoY Growth 2016-2027 7.2 North America Cefepime Market Facts & Figures by Country 7.2.1 North America Cefepime Sales by Country (2016-2021) 7.2.2 North America Cefepime Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Cefepime Market Size YoY Growth 2016-2027 8.2 Asia Pacific Cefepime Market Facts & Figures by Region 8.2.1 Asia Pacific Cefepime Sales by Region (2016-2021) 8.2.2 Asia Pacific Cefepime Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Cefepime Market Size YoY Growth 2016-2027 9.2 Europe Cefepime Market Facts & Figures by Country 9.2.1 Europe Cefepime Sales by Country (2016-2021) 9.2.2 Europe Cefepime Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Cefepime Market Size YoY Growth 2016-2027 10.2 Latin America Cefepime Market Facts & Figures by Country 10.2.1 Latin America Cefepime Sales by Country (2016-2021) 10.2.2 Latin America Cefepime Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Cefepime Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Cefepime Market Facts & Figures by Country 11.2.1 Middle East and Africa Cefepime Sales by Country (2016-2021) 11.2.2 Middle East and Africa Cefepime Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Baxter 12.1.1 Baxter Corporation Information 12.1.2 Baxter Description and Business Overview 12.1.3 Baxter Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Baxter Cefepime Products Offered 12.1.5 Baxter Recent Development 12.2 Apotex 12.2.1 Apotex Corporation Information 12.2.2 Apotex Description and Business Overview 12.2.3 Apotex Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Apotex Cefepime Products Offered 12.2.5 Apotex Recent Development 12.3 B. Braun Medical 12.3.1 B. Braun Medical Corporation Information 12.3.2 B. Braun Medical Description and Business Overview 12.3.3 B. Braun Medical Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.3.4 B. Braun Medical Cefepime Products Offered 12.3.5 B. Braun Medical Recent Development 12.4 Pfizer 12.4.1 Pfizer Corporation Information 12.4.2 Pfizer Description and Business Overview 12.4.3 Pfizer Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Pfizer Cefepime Products Offered 12.4.5 Pfizer Recent Development 12.5 Perrigo 12.5.1 Perrigo Corporation Information 12.5.2 Perrigo Description and Business Overview 12.5.3 Perrigo Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Perrigo Cefepime Products Offered 12.5.5 Perrigo Recent Development 12.6 Fresenius Kabi 12.6.1 Fresenius Kabi Corporation Information 12.6.2 Fresenius Kabi Description and Business Overview 12.6.3 Fresenius Kabi Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Fresenius Kabi Cefepime Products Offered 12.6.5 Fresenius Kabi Recent Development 12.7 Sandoz (Novartis) 12.7.1 Sandoz (Novartis) Corporation Information 12.7.2 Sandoz (Novartis) Description and Business Overview 12.7.3 Sandoz (Novartis) Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Sandoz (Novartis) Cefepime Products Offered 12.7.5 Sandoz (Novartis) Recent Development 12.8 Piramal Critical Care 12.8.1 Piramal Critical Care Corporation Information 12.8.2 Piramal Critical Care Description and Business Overview 12.8.3 Piramal Critical Care Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Piramal Critical Care Cefepime Products Offered 12.8.5 Piramal Critical Care Recent Development 12.9 Meitheal Pharmaceuticals 12.9.1 Meitheal Pharmaceuticals Corporation Information 12.9.2 Meitheal Pharmaceuticals Description and Business Overview 12.9.3 Meitheal Pharmaceuticals Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Meitheal Pharmaceuticals Cefepime Products Offered 12.9.5 Meitheal Pharmaceuticals Recent Development 12.10 BMS 12.10.1 BMS Corporation Information 12.10.2 BMS Description and Business Overview 12.10.3 BMS Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.10.4 BMS Cefepime Products Offered 12.10.5 BMS Recent Development 12.11 Baxter 12.11.1 Baxter Corporation Information 12.11.2 Baxter Description and Business Overview 12.11.3 Baxter Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Baxter Cefepime Products Offered 12.11.5 Baxter Recent Development 12.12 Sinopharm 12.12.1 Sinopharm Corporation Information 12.12.2 Sinopharm Description and Business Overview 12.12.3 Sinopharm Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Sinopharm Products Offered 12.12.5 Sinopharm Recent Development 12.13 Shanghai Xinfeng Pharmaceutical 12.13.1 Shanghai Xinfeng Pharmaceutical Corporation Information 12.13.2 Shanghai Xinfeng Pharmaceutical Description and Business Overview 12.13.3 Shanghai Xinfeng Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Shanghai Xinfeng Pharmaceutical Products Offered 12.13.5 Shanghai Xinfeng Pharmaceutical Recent Development 12.14 Hebei Huamin Pharmaceutical 12.14.1 Hebei Huamin Pharmaceutical Corporation Information 12.14.2 Hebei Huamin Pharmaceutical Description and Business Overview 12.14.3 Hebei Huamin Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Hebei Huamin Pharmaceutical Products Offered 12.14.5 Hebei Huamin Pharmaceutical Recent Development 12.15 Nanjing Haichen Pharmaceutical 12.15.1 Nanjing Haichen Pharmaceutical Corporation Information 12.15.2 Nanjing Haichen Pharmaceutical Description and Business Overview 12.15.3 Nanjing Haichen Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Nanjing Haichen Pharmaceutical Products Offered 12.15.5 Nanjing Haichen Pharmaceutical Recent Development 12.16 Shandong Luoxin Pharmaceutical Group 12.16.1 Shandong Luoxin Pharmaceutical Group Corporation Information 12.16.2 Shandong Luoxin Pharmaceutical Group Description and Business Overview 12.16.3 Shandong Luoxin Pharmaceutical Group Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Shandong Luoxin Pharmaceutical Group Products Offered 12.16.5 Shandong Luoxin Pharmaceutical Group Recent Development 12.17 Guangzhou Baiyunshan Tianxin Pharmaceutical 12.17.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Corporation Information 12.17.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Description and Business Overview 12.17.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.17.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Products Offered 12.17.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Recent Development 12.18 Yuekang Pharmaceutical Group 12.18.1 Yuekang Pharmaceutical Group Corporation Information 12.18.2 Yuekang Pharmaceutical Group Description and Business Overview 12.18.3 Yuekang Pharmaceutical Group Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.18.4 Yuekang Pharmaceutical Group Products Offered 12.18.5 Yuekang Pharmaceutical Group Recent Development 12.19 Chengdu Beite Pharmaceutical 12.19.1 Chengdu Beite Pharmaceutical Corporation Information 12.19.2 Chengdu Beite Pharmaceutical Description and Business Overview 12.19.3 Chengdu Beite Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.19.4 Chengdu Beite Pharmaceutical Products Offered 12.19.5 Chengdu Beite Pharmaceutical Recent Development 12.20 Jiangsu Hengrui Pharmaceutical 12.20.1 Jiangsu Hengrui Pharmaceutical Corporation Information 12.20.2 Jiangsu Hengrui Pharmaceutical Description and Business Overview 12.20.3 Jiangsu Hengrui Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.20.4 Jiangsu Hengrui Pharmaceutical Products Offered 12.20.5 Jiangsu Hengrui Pharmaceutical Recent Development 12.21 Hainan Star Pharmaceutical 12.21.1 Hainan Star Pharmaceutical Corporation Information 12.21.2 Hainan Star Pharmaceutical Description and Business Overview 12.21.3 Hainan Star Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.21.4 Hainan Star Pharmaceutical Products Offered 12.21.5 Hainan Star Pharmaceutical Recent Development 12.22 Hainan Hailing Pharmaceutical 12.22.1 Hainan Hailing Pharmaceutical Corporation Information 12.22.2 Hainan Hailing Pharmaceutical Description and Business Overview 12.22.3 Hainan Hailing Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.22.4 Hainan Hailing Pharmaceutical Products Offered 12.22.5 Hainan Hailing Pharmaceutical Recent Development 12.23 Shenzhen Xinlitai Pharmaceutical 12.23.1 Shenzhen Xinlitai Pharmaceutical Corporation Information 12.23.2 Shenzhen Xinlitai Pharmaceutical Description and Business Overview 12.23.3 Shenzhen Xinlitai Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.23.4 Shenzhen Xinlitai Pharmaceutical Products Offered 12.23.5 Shenzhen Xinlitai Pharmaceutical Recent Development 12.24 Shenzhen Lijian Pharmaceutical 12.24.1 Shenzhen Lijian Pharmaceutical Corporation Information 12.24.2 Shenzhen Lijian Pharmaceutical Description and Business Overview 12.24.3 Shenzhen Lijian Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.24.4 Shenzhen Lijian Pharmaceutical Products Offered 12.24.5 Shenzhen Lijian Pharmaceutical Recent Development 12.25 Suzhou Dongrui Pharmaceutical 12.25.1 Suzhou Dongrui Pharmaceutical Corporation Information 12.25.2 Suzhou Dongrui Pharmaceutical Description and Business Overview 12.25.3 Suzhou Dongrui Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.25.4 Suzhou Dongrui Pharmaceutical Products Offered 12.25.5 Suzhou Dongrui Pharmaceutical Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Cefepime Industry Trends 13.2 Cefepime Market Drivers 13.3 Cefepime Market Challenges 13.4 Cefepime Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Cefepime Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer
SummaryCefepime is a fourth-generation cephalosporin.Its antibacterial spectrum has been further expanded, and it has strong antibacterial activity against a variety of gram-positive and negative bacteria, including enterobacteria, pseudomonas aeruginosa and other non-fermenter bacilli, haemophilus, staphylococcus, etc.Used for various infections caused by sensitive bacteria, mainly for respiratory tract infections caused by vicarious infections such as s. aureus, e. coli and pseudomonas aeruginosa. Table of Contents1 Study Coverage1.1 Cefepime Product Introduction 1.2 Market by Type 1.2.1 Global Cefepime Market Size Growth Rate by Type 1.2.2 Intramuscular Injection 1.2.3 Intravenous Drug Delivery 1.3 Market by Application 1.3.1 Global Cefepime Market Size Growth Rate by Application 1.3.2 Lower Respiratory Tract Infection 1.3.3 Urinary Tract Infection 1.3.4 Skin And Soft Tissue Infections 1.3.5 Abdominal Cavity Infection 1.3.6 Gynecologic Infection 1.3.7 Sepsis 1.3.8 Neutrophilic Fever 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Cefepime Market Size, Estimates and Forecasts 2.1.1 Global Cefepime Revenue 2016-2027 2.1.2 Global Cefepime Sales 2016-2027 2.2 Global Cefepime, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Cefepime Historical Market Size by Region (2016-2021) 2.3.1 Global Cefepime Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Cefepime Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Cefepime Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Cefepime Sales Forecast by Region (2022-2027) 2.4.2 Global Cefepime Revenue Forecast by Region (2022-2027) 3 Global Cefepime Competitor Landscape by Players 3.1 Global Top Cefepime Manufacturers by Sales 3.1.1 Global Cefepime Sales by Manufacturer (2016-2021) 3.1.2 Global Cefepime Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Cefepime Manufacturers by Revenue 3.2.1 Key Cefepime Manufacturers Covered: Ranking by Revenue 3.2.2 Global Cefepime Revenue by Manufacturers (2016-2021) 3.2.3 Global Cefepime Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Cefepime Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Cefepime Revenue in 2020 3.2.6 Global Cefepime Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Cefepime Price by Manufacturers 3.4 Global Cefepime Manufacturing Base Distribution, Product Types 3.4.1 Cefepime Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Cefepime Product Type 3.4.3 Date of International Manufacturers Enter into Cefepime Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Cefepime Market Size by Type (2016-2021) 4.1.1 Global Cefepime Sales by Type (2016-2021) 4.1.2 Global Cefepime Revenue by Type (2016-2021) 4.1.3 Cefepime Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Cefepime Market Size Forecast by Type (2022-2027) 4.2.1 Global Cefepime Sales Forecast by Type (2022-2027) 4.2.2 Global Cefepime Revenue Forecast by Type (2022-2027) 4.2.3 Cefepime Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Cefepime Market Size by Application (2016-2021) 5.1.1 Global Cefepime Sales by Application (2016-2021) 5.1.2 Global Cefepime Revenue by Application (2016-2021) 5.1.3 Cefepime Price by Application (2016-2021) 5.2 Cefepime Market Size Forecast by Application (2022-2027) 5.2.1 Global Cefepime Sales Forecast by Application (2022-2027) 5.2.2 Global Cefepime Revenue Forecast by Application (2022-2027) 5.2.3 Global Cefepime Price Forecast by Application (2022-2027) 6 United States by Players, Type and Application 6.1 United States Cefepime Market Size YoY Growth 2016-2027 6.1.1 United States Cefepime Sales YoY Growth 2016-2027 6.1.2 United States Cefepime Revenue YoY Growth 2016-2027 6.1.3 United States Cefepime Market Share in Global Market 2016-2027 6.2 United States Cefepime Market Size by Players (International and Local Players) 6.2.1 United States Top Cefepime Players by Sales (2016-2021) 6.2.2 United States Top Cefepime Players by Revenue (2016-2021) 6.3 United States Cefepime Historic Market Review by Type (2016-2021) 6.3.1 United States Cefepime Sales Market Share by Type (2016-2021) 6.3.2 United States Cefepime Revenue Market Share by Type (2016-2021) 6.3.3 United States Cefepime Price by Type (2016-2021) 6.4 United States Cefepime Market Estimates and Forecasts by Type (2022-2027) 6.4.1 United States Cefepime Sales Forecast by Type (2022-2027) 6.4.2 United States Cefepime Revenue Forecast by Type (2022-2027) 6.4.3 United States Cefepime Price Forecast by Type (2022-2027) 6.5 United States Cefepime Historic Market Review by Application (2016-2021) 6.5.1 United States Cefepime Sales Market Share by Application (2016-2021) 6.5.2 United States Cefepime Revenue Market Share by Application (2016-2021) 6.5.3 United States Cefepime Price by Application (2016-2021) 6.6 United States Cefepime Market Estimates and Forecasts by Application (2022-2027) 6.6.1 United States Cefepime Sales Forecast by Application (2022-2027) 6.6.2 United States Cefepime Revenue Forecast by Application (2022-2027) 6.6.3 United States Cefepime Price Forecast by Application (2022-2027) 7 North America 7.1 North America Cefepime Market Size YoY Growth 2016-2027 7.2 North America Cefepime Market Facts & Figures by Country 7.2.1 North America Cefepime Sales by Country (2016-2021) 7.2.2 North America Cefepime Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Cefepime Market Size YoY Growth 2016-2027 8.2 Asia Pacific Cefepime Market Facts & Figures by Region 8.2.1 Asia Pacific Cefepime Sales by Region (2016-2021) 8.2.2 Asia Pacific Cefepime Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Cefepime Market Size YoY Growth 2016-2027 9.2 Europe Cefepime Market Facts & Figures by Country 9.2.1 Europe Cefepime Sales by Country (2016-2021) 9.2.2 Europe Cefepime Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Cefepime Market Size YoY Growth 2016-2027 10.2 Latin America Cefepime Market Facts & Figures by Country 10.2.1 Latin America Cefepime Sales by Country (2016-2021) 10.2.2 Latin America Cefepime Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Cefepime Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Cefepime Market Facts & Figures by Country 11.2.1 Middle East and Africa Cefepime Sales by Country (2016-2021) 11.2.2 Middle East and Africa Cefepime Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Baxter 12.1.1 Baxter Corporation Information 12.1.2 Baxter Description and Business Overview 12.1.3 Baxter Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Baxter Cefepime Products Offered 12.1.5 Baxter Recent Development 12.2 Apotex 12.2.1 Apotex Corporation Information 12.2.2 Apotex Description and Business Overview 12.2.3 Apotex Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Apotex Cefepime Products Offered 12.2.5 Apotex Recent Development 12.3 B. Braun Medical 12.3.1 B. Braun Medical Corporation Information 12.3.2 B. Braun Medical Description and Business Overview 12.3.3 B. Braun Medical Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.3.4 B. Braun Medical Cefepime Products Offered 12.3.5 B. Braun Medical Recent Development 12.4 Pfizer 12.4.1 Pfizer Corporation Information 12.4.2 Pfizer Description and Business Overview 12.4.3 Pfizer Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Pfizer Cefepime Products Offered 12.4.5 Pfizer Recent Development 12.5 Perrigo 12.5.1 Perrigo Corporation Information 12.5.2 Perrigo Description and Business Overview 12.5.3 Perrigo Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Perrigo Cefepime Products Offered 12.5.5 Perrigo Recent Development 12.6 Fresenius Kabi 12.6.1 Fresenius Kabi Corporation Information 12.6.2 Fresenius Kabi Description and Business Overview 12.6.3 Fresenius Kabi Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Fresenius Kabi Cefepime Products Offered 12.6.5 Fresenius Kabi Recent Development 12.7 Sandoz (Novartis) 12.7.1 Sandoz (Novartis) Corporation Information 12.7.2 Sandoz (Novartis) Description and Business Overview 12.7.3 Sandoz (Novartis) Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Sandoz (Novartis) Cefepime Products Offered 12.7.5 Sandoz (Novartis) Recent Development 12.8 Piramal Critical Care 12.8.1 Piramal Critical Care Corporation Information 12.8.2 Piramal Critical Care Description and Business Overview 12.8.3 Piramal Critical Care Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Piramal Critical Care Cefepime Products Offered 12.8.5 Piramal Critical Care Recent Development 12.9 Meitheal Pharmaceuticals 12.9.1 Meitheal Pharmaceuticals Corporation Information 12.9.2 Meitheal Pharmaceuticals Description and Business Overview 12.9.3 Meitheal Pharmaceuticals Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Meitheal Pharmaceuticals Cefepime Products Offered 12.9.5 Meitheal Pharmaceuticals Recent Development 12.10 BMS 12.10.1 BMS Corporation Information 12.10.2 BMS Description and Business Overview 12.10.3 BMS Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.10.4 BMS Cefepime Products Offered 12.10.5 BMS Recent Development 12.11 Baxter 12.11.1 Baxter Corporation Information 12.11.2 Baxter Description and Business Overview 12.11.3 Baxter Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Baxter Cefepime Products Offered 12.11.5 Baxter Recent Development 12.12 Sinopharm 12.12.1 Sinopharm Corporation Information 12.12.2 Sinopharm Description and Business Overview 12.12.3 Sinopharm Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Sinopharm Products Offered 12.12.5 Sinopharm Recent Development 12.13 Shanghai Xinfeng Pharmaceutical 12.13.1 Shanghai Xinfeng Pharmaceutical Corporation Information 12.13.2 Shanghai Xinfeng Pharmaceutical Description and Business Overview 12.13.3 Shanghai Xinfeng Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Shanghai Xinfeng Pharmaceutical Products Offered 12.13.5 Shanghai Xinfeng Pharmaceutical Recent Development 12.14 Hebei Huamin Pharmaceutical 12.14.1 Hebei Huamin Pharmaceutical Corporation Information 12.14.2 Hebei Huamin Pharmaceutical Description and Business Overview 12.14.3 Hebei Huamin Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Hebei Huamin Pharmaceutical Products Offered 12.14.5 Hebei Huamin Pharmaceutical Recent Development 12.15 Nanjing Haichen Pharmaceutical 12.15.1 Nanjing Haichen Pharmaceutical Corporation Information 12.15.2 Nanjing Haichen Pharmaceutical Description and Business Overview 12.15.3 Nanjing Haichen Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Nanjing Haichen Pharmaceutical Products Offered 12.15.5 Nanjing Haichen Pharmaceutical Recent Development 12.16 Shandong Luoxin Pharmaceutical Group 12.16.1 Shandong Luoxin Pharmaceutical Group Corporation Information 12.16.2 Shandong Luoxin Pharmaceutical Group Description and Business Overview 12.16.3 Shandong Luoxin Pharmaceutical Group Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Shandong Luoxin Pharmaceutical Group Products Offered 12.16.5 Shandong Luoxin Pharmaceutical Group Recent Development 12.17 Guangzhou Baiyunshan Tianxin Pharmaceutical 12.17.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Corporation Information 12.17.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Description and Business Overview 12.17.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.17.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Products Offered 12.17.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Recent Development 12.18 Yuekang Pharmaceutical Group 12.18.1 Yuekang Pharmaceutical Group Corporation Information 12.18.2 Yuekang Pharmaceutical Group Description and Business Overview 12.18.3 Yuekang Pharmaceutical Group Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.18.4 Yuekang Pharmaceutical Group Products Offered 12.18.5 Yuekang Pharmaceutical Group Recent Development 12.19 Chengdu Beite Pharmaceutical 12.19.1 Chengdu Beite Pharmaceutical Corporation Information 12.19.2 Chengdu Beite Pharmaceutical Description and Business Overview 12.19.3 Chengdu Beite Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.19.4 Chengdu Beite Pharmaceutical Products Offered 12.19.5 Chengdu Beite Pharmaceutical Recent Development 12.20 Jiangsu Hengrui Pharmaceutical 12.20.1 Jiangsu Hengrui Pharmaceutical Corporation Information 12.20.2 Jiangsu Hengrui Pharmaceutical Description and Business Overview 12.20.3 Jiangsu Hengrui Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.20.4 Jiangsu Hengrui Pharmaceutical Products Offered 12.20.5 Jiangsu Hengrui Pharmaceutical Recent Development 12.21 Hainan Star Pharmaceutical 12.21.1 Hainan Star Pharmaceutical Corporation Information 12.21.2 Hainan Star Pharmaceutical Description and Business Overview 12.21.3 Hainan Star Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.21.4 Hainan Star Pharmaceutical Products Offered 12.21.5 Hainan Star Pharmaceutical Recent Development 12.22 Hainan Hailing Pharmaceutical 12.22.1 Hainan Hailing Pharmaceutical Corporation Information 12.22.2 Hainan Hailing Pharmaceutical Description and Business Overview 12.22.3 Hainan Hailing Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.22.4 Hainan Hailing Pharmaceutical Products Offered 12.22.5 Hainan Hailing Pharmaceutical Recent Development 12.23 Shenzhen Xinlitai Pharmaceutical 12.23.1 Shenzhen Xinlitai Pharmaceutical Corporation Information 12.23.2 Shenzhen Xinlitai Pharmaceutical Description and Business Overview 12.23.3 Shenzhen Xinlitai Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.23.4 Shenzhen Xinlitai Pharmaceutical Products Offered 12.23.5 Shenzhen Xinlitai Pharmaceutical Recent Development 12.24 Shenzhen Lijian Pharmaceutical 12.24.1 Shenzhen Lijian Pharmaceutical Corporation Information 12.24.2 Shenzhen Lijian Pharmaceutical Description and Business Overview 12.24.3 Shenzhen Lijian Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.24.4 Shenzhen Lijian Pharmaceutical Products Offered 12.24.5 Shenzhen Lijian Pharmaceutical Recent Development 12.25 Suzhou Dongrui Pharmaceutical 12.25.1 Suzhou Dongrui Pharmaceutical Corporation Information 12.25.2 Suzhou Dongrui Pharmaceutical Description and Business Overview 12.25.3 Suzhou Dongrui Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021) 12.25.4 Suzhou Dongrui Pharmaceutical Products Offered 12.25.5 Suzhou Dongrui Pharmaceutical Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Cefepime Industry Trends 13.2 Cefepime Market Drivers 13.3 Cefepime Market Challenges 13.4 Cefepime Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Cefepime Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野の最新刊レポート
QYResearch社の分野での最新刊レポート
本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2025/03/14 10:26 149.35 円 162.52 円 196.23 円 |